title: Molecular profiling for druggable genetic abnormalities in carcinoma of unknown primary.
authors.affiliation: Department of Medical Oncology, National Cancer Center Singapore, 11 Hospital Dr, Singapore. daniel.tan.s.w@nccs.com.sg
authors.forename: Daniel S-W
authors.initials: DS
authors.lastname: Tan
authors.forename: Joey
authors.initials: J
authors.lastname: Montoya
authors.forename: Quan-Sing
authors.initials: QS
authors.lastname: Ng
authors.forename: Kian-Sing
authors.initials: KS
authors.lastname: Chan
authors.forename: Oon
authors.initials: O
authors.lastname: Lynette
authors.forename: Sai
authors.initials: S
authors.lastname: Sakktee Krisna
authors.forename: Angela
authors.initials: A
authors.lastname: Takano
authors.forename: Wan-Teck
authors.initials: WT
authors.lastname: Lim
authors.forename: Eng-Huat
authors.initials: EH
authors.lastname: Tan
authors.forename: Kiat-Hon
authors.initials: KH
authors.lastname: Lim
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001120:Arginine; D001706:Biopsy; D016190:Carboplatin / Q000008:administration & dosage; D002277:Carcinoma / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D018572:Disease-Free Survival; D066246:ErbB Receptors / Q000235:genetics*; D000077156:Gefitinib; D006801:Humans; D007150:Immunohistochemistry; D007930:Leucine; D008297:Male; D008875:Middle Aged; D058990:Molecular Targeted Therapy / Q000379:methods; D009367:Neoplasm Staging; D009382:Neoplasms, Unknown Primary / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D017354:Point Mutation; D011799:Quinazolines / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D000093542:Gemcitabine
chemical_list: D011799:Quinazolines; D003841:Deoxycytidine; D001120:Arginine; D016190:Carboplatin; C512478:EGFR protein, human; D066246:ErbB Receptors; D007930:Leucine; D000077156:Gefitinib; D000093542:Gemcitabine